Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 6/20 | 0.72 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.72 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.72 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.72 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 0.72 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.72 |
| ▸ | HDAC10 | Q969S8 | 5/20 | 0.72 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.72 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.72 |
| ▸ | HDAC9 | Q9UKV0 | 5/20 | 0.72 |
| ▸ | HDAC5 | Q9UQL6 | 5/20 | 0.72 |
| ▸ | BCHE | P06276 | 6/20 | 0.65 |
| ▸ | ACHE | P22303 | 6/20 | 0.65 |
| ▸ | MAOA | P21397 | 1/20 | 0.64 |
| ▸ | CCR3 | P51677 | 1/20 | 0.60 |
| ▸ | DRD2 | P14416 | 1/20 | 0.60 |
| ▸ | HTR2A | P28223 | 1/20 | 0.60 |
| ▸ | HTR2C | P28335 | 1/20 | 0.60 |
| ▸ | HTR2B | P41595 | 1/20 | 0.60 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL726133 | 1.00 | HDAC8 (0.72) | HDAC8HDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL724056 | 0.88 | HDAC1 (0.69) | HDAC8HDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL1486886 | 0.88 | HDAC1 (0.69) | HDAC8HDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL28639623 | 0.84 | HDAC8 (1.00) | HDAC8HDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL28639626 | 0.84 | HDAC8 (1.00) | HDAC8HDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL1415614 | 0.81 | HDAC8 (0.65) | HDAC8HDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL1415618 | 0.81 | HDAC8 (0.65) | HDAC8HDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL1415616 | 0.81 | HDAC8 (0.65) | HDAC8HDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL30887590 | 0.81 | HDAC1 (0.63) | HDAC8HDAC1HDAC3HDAC4HDAC7 | |
| SCHEMBL1481725 | 0.81 | HDAC1 (0.80) | HDAC8HDAC1HDAC3HDAC4HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110053925-A1 | Hydroxamate-Based Inhibitors of Deacetylases | NOVARTIS AG | 2011-03-03 | — | — | US | claimed |
| WO-2012025155-A1 | HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES | NOVARTIS AG (CH) | 2012-03-01 | — | — | WO | disclosed |
| US-20110053925-A1 | Hydroxamate-Based Inhibitors of Deacetylases | NOVARTIS AG | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110053925-A1 | Hydroxamate-Based Inhibitors of Deacetylases | HDAC1, HDAC11, HDAC3 | HDAC8 8/4885HDAC1 1/4885HDAC3 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.